Status and phase
Conditions
Treatments
About
This is an open-label, randomised, single-dose, 3 arms study design.
Full description
Subjects will be randomised into one of 3 arms, in a 1:1:1 ratio, wearing BUP TDS 20 mg for 3 days or 40 mg for 3 days or 40 mg for 4 days.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
45 participants in 3 patient groups
Loading...
Central trial contact
Rongna A, Master; Di Yang, Bachelor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal